PPD, Inc. 3 SEC Filings

Filed On	Filing
18 Oct 2021	Form 3: Pharmaceutical Product DEVELOPMENT, Llc, 10% owner and 5 others · Science 37 Holdings, Inc. Holds 17,314,315 shares of Common Stock
09 Feb 2021	Form 3: James Julia, EVP, General Counsel Holds 21,470 shares of Common Stock
12 Jun 2020	Form 3: Pellegrino Jill, SVP & General Manager of AES Holds 2,658 shares of Common stock
05 Feb 2020	Form 3: Thakral Anshul, EVP, Chief Commercial Officer Holds 34,226 shares of Non-voting common stock
05 Feb 2020	Form 3: Fikry Christopher, EVP, Global Laboratory Service Holds 6,645 shares of Non-voting common stock
05 Feb 2020	Form 3: Scully Christopher G., See Remarks
05 Feb 2020	Form 3: Hartman Judd, See Remarks Holds 94,166 shares of Non-voting common stock
05 Feb 2020	Form 3: Johnston David Michael, See Remarks Holds 93,107 shares of Non-voting common stock
05 Feb 2020	Form 3: Hill Colin, Director Holds 12,160 shares of Non-voting common stock
05 Feb 2020	Form 3: H&F Corporate Investors VII, Ltd., 10% owner and 5 others Holds 63,069,561 shares of Common Stock
05 Feb 2020	Form 3: Kindler Jeffrey B, Director Holds 93,595 shares of Non-voting common stock
05 Feb 2020	Form 3: Donovan Glen, Chief Accounting Officer Holds 5,333 shares of Non-voting common stock
05 Feb 2020	Form 3: Bress Joe, Director No securities owned
05 Feb 2020	Form 3: Hilado Maria Teresa, Director Holds 25,471 shares of Non-voting common stock
05 Feb 2020	Form 3: H&F Corporate Investors VIII, Ltd., 10% owner and 7 others Holds 63,069,561 shares of Common Stock
05 Feb 2020	Form 3: Philbrick P. Hunter, Director No securities owned
05 Feb 2020	Form 3: Kaucic Karen, See Remarks Holds 28,966 shares of Non-voting common stock
05 Feb 2020	Form 3: Simmons David S, Director Holds 867,759 shares of Non-voting common stock
05 Feb 2020	Form 3: Ensley Stephen, Director No securities owned
05 Feb 2020	Form 3: Smith Roger Dale, SVP & General Manager of AES Holds 32,959 shares of Non-voting common stock

Comments